Testing a glucose control system in simulated ICU conditions
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a closed-loop glucose monitoring and insulin delivery system (like an artificial pancreas) in a controlled hospital-like setting. Researchers will monitor how well it manages blood sugar in people with type 1 or type 2 diabetes who use insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes and have been using insulin injections at home for at least 3 months
- Your hemoglobin A1c (average blood sugar over 3 months) is between 7.0–10.0%
- You are between 18 and 70 years old and weigh between 40–150 kg (88–330 lbs)
- You have healthy veins in your upper arms for sensors and catheters
- You have no serious liver, kidney, heart, or neurological conditions
- You have not been in another medical study in the past 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
This trial tests using a continuous glucose monitor to track blood sugar levels in intensive care patients. The monitor sends readings wirelessly, which may help doctors adjust insulin more quickly and safely.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This trial tests a digital diabetes management tool for people with type 2 diabetes or new high blood sugar who need insulin injections while in the hospital. It aims to see if this tool helps control blood sugar better.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.